Company Profile

Medica S.p.A. is specialized in the design, manufacture and marketing of medical products and devices for use in blood filtration. The group also offers electro-medical equipment and water purification products. The business is organized around 3 groups of products:
- medical equipment and devices for blood filtration and acute medical treatments: medical equipment and devices for intensive care units (products for apheresis, dialysis, treatment of acute renal failure and heart failure, organ transplantation, bio-regenerative medicine, and intraperitoneal chemohyperthermia), single-use products for hemodialysis, disposable products for gastroenterology and urodynamic examinations;
- automated machines for the production and assembly of medical devices (Tecnoideal);
- microbiological water purification products and systems: for medical, home, commercial and industrial applications.
At the end of 2022, the group had 6 production sites in Italy (3), the United States, the United Kingdom and Tunisia.
Net sales are distributed as follows: Italy (36.2%), Europe (31.1%) and other (32.7%).


Source: Cofisem - Last Update: 2024-03-27

Key Executives
Chief Executive Officer Marco Fecondini
Chief Financial Officer Giovanni Plasmati
Chief Investor Relations Officer Giovanni Plasmati


Source: Cofisem - Last Update: 2024-03-27

Key Figures
Millenium 2023 2022 2021 2020 2019
Net sales 79,979 50,864 43,799 44,060 34,672
Consumed purchases 34,812 17,220 15,215 16,666 12,448
Labour costs 19,995 15,971 13,205 12,448 11,363
Operating profit 4,560 5,264 5,824 5,592 3,597
Income tax 917 798 637 1,450 520
Net income 2,493 4,014 4,980 3,848 2,820
Net income (Group share) 2,967 4,351 4,973 3,772 2,781
Fiscal year end 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - thousands EUR - thousands EUR - thousands EUR - thousands EUR - thousands
Account Standards US GAAP US GAAP US GAAP US GAAP US GAAP

Source: Cofisem - Last Update: 2024-03-27

Shareholder information
Azimut Investments SA 5.4 %
Free float 14.67 %
Pelmo87 S.R.L. 79.93 %


Source: Cofisem - Last Update: 2024-03-27

Please contact MyQuestion.Italy@euronext.com for Company Profile support.

Quotazioni, Book, Dividendi, Documenti Societari, Corporate Governance, Internal Dealing di Medica


The Exchange accepts no responsability for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.


You will be redirected in five seconds.